MEDFORD, N.Y.--(BUSINESS WIRE)--March 13, 2006--Chembio is pleased by the recommendation that was given to the Food & Drug Administration (FDA) by FDA's Blood Products Advisory Committee (BPAC) on Friday, March 10 concerning proposed regulatory requirements for the approval of over the counter (OTC) distribution of rapid HIV tests.
